WHO ICTRP trial
A Phase I clinical trial to investigate the safety and tolerability of NK105…
JPRN-jRCT2080223202 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080223202 |
|---|---|
| Public title | A Phase I clinical trial to investigate the safety and tolerability of NK105 when co-administered with carboplatin once per week to Japanese patients with advanced solid cancers. |
| Scientific title | A Phase I clinical trial to investigate the safety and tolerability of NK105 when co-administered with carboplatin once per week to Japanese patients with advanced solid cancers. |
| Primary sponsor | Nippon Kayaku Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 1 |
| Conditions | Advanced solid cancers |
| Interventions | investigational material(s) Generic name etc : NK105 INN of investigational material : Therapeutic category code : 424 Antineoplastic preparations extracted from plants Dosage and Administration for Investigational material : Intravenous |
| Registration date | May 18, 2016 |
| Target size | 18 |
| Secondary IDs | JapicCTI-163257 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: